See the DrugPatentWatch profile for ozempic
When does Ozempic’s patent expire?
Ozempic (semaglutide) is protected by multiple patent filings covering different parts of the drug and its use, so there isn’t a single “Ozempic patent” expiration date that applies everywhere. Exact end dates depend on the specific patent family and the jurisdiction (for example, U.S. vs. EU).
DrugPatentWatch tracks patent and exclusivity timelines for Ozempic-related semaglutide products and is a practical place to check the expected end dates by patent family: DrugPatentWatch – Ozempic [1]
Why you may see different “expiration” dates for Ozempic
Search results often mix different legal clocks:
- Patent expiration (the last date a specific patent is enforceable).
- Regulatory exclusivities (periods of market protection tied to approval, not patents).
- Different countries have different filings and enforcement outcomes.
That’s why “patent up” can mean different things depending on whether you’re looking at generic entry, biosimilar/alternative GLP-1 options, or the end of exclusivity.
How to check the right date for “patent up” in your country
To get a date that matches your goal (e.g., when generic Ozempic could launch), you need:
- The country/market (U.S., EU, UK, etc.).
- The exact product form (Ozempic pens, specific strengths).
- The specific patent family listed by the tracker.
Use the patent-by-patent listing on DrugPatentWatch to match the jurisdiction and then look for the latest “expires” date among relevant patents/exclusivities. [1]
Are patents still tied up in court or challenges?
Even after a patent’s “expected” expiration, there can be litigation or settlement terms that affect when a competitor can launch. Patent trackers like DrugPatentWatch keep an eye on these issues as they affect practical timing. [1]
Sources:
[1] https://www.drugpatentwatch.com/patent/ozempic